AMLX20261016P42
AMLX Oct 16 2026 42.00 Put (AMLX261016P00042000)
option OPRA

Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.